What does Goldspan Health cost?

We cannot tell you, and neither can its website. We crawled eighteen pages — homepage, all eleven category pages, about, how it works, the quiz and three legal pages — and found no price for any product or lab panel. Every path ends at a two-minute quiz or a "create an account to learn more" wall. Only one other provider in this batch, Solaya MD, publishes as little. If price comparison is part of your decision, you will have to register to participate in it.

What does "NO GRAY MARKET. NO RUO." actually mean?

RUO stands for research use only — vials sold as laboratory material, labeled not for human use, which a large gray market supplies to consumers who inject them anyway. By putting that line on its homepage, Goldspan is drawing a distinction between itself and that trade: it is saying everything it dispenses is a prescription compounded by a licensed 503A or 503B pharmacy. We think the distinction is the right one, and it is worth knowing that it exists — we refused a company from this same list, OzielRx, precisely because it sells research-use-only vials rather than prescriptions.

Who actually prescribes and compounds?

Prescribing is done by clinicians from Altro Health, which Goldspan names as its clinical infrastructure partner across the category pages and in its footer. Compounding is restricted to licensed 503A and 503B pharmacies — stated many times — but no individual pharmacy is named. Naming the clinical partner is more than most of this batch does; naming the specific pharmacy, as Clume Health and Nex Gen Health Rx do, would be more.

What is the difference between the B12 and glycine versions?

Goldspan offers both semaglutide and tirzepatide as an injection compounded either with B12 "for energy" or with glycine "for muscle maintenance". That framing is more considered than the usual B12 default, but treat the claimed benefits carefully: B12 is added routinely across this industry and its energy benefit in people who are not deficient is not established, and glycine as a compounding base is not the same as a studied intervention for preserving lean mass during GLP-1 treatment. Resistance training and adequate protein are the interventions with actual evidence behind them.

Updated September 2026

Goldspan Health review

Sourcing named, price not

Restricts itself to 503A and 503B pharmacies, names its clinical partner, disallows research-grade product — and publishes no price at all.

Our verdict

Goldspan is the most carefully positioned service in this batch and the hardest to recommend acting on. Its sourcing discipline is real and stated in terms most competitors avoid: compounding restricted to licensed 503A and 503B pharmacies, clinical infrastructure supplied by a named partner in Altro Health, lab work through Quest Diagnostics, and a banner that reads "NO GRAY MARKET. NO RUO." — an explicit rejection of the research-use-only vial trade that surrounds this category. Its weight-loss line even offers a considered choice, tirzepatide or semaglutide with B12 for energy or glycine for muscle maintenance. But across eighteen pages we found no price for anything, so you cannot compare it with anything here without starting an intake. It also calls estradiol and anastrozole peptides, which for a service selling peptide expertise is a careless error.

Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.

Check availability →No price published anywhere on the public site; quiz-gated. 503A/503B only, Quest labs, 50 states

At a glance

Category: GLP-1 telehealth
Access: No price published anywhere on the public site; quiz-gated. 503A/503B only, Quest labs, 50 states
Medications: Compounded semaglutide · Compounded tirzepatide
Visit: Quiz intake
Availability: 50 states
Updated: September 2026

What it is

A longevity-positioned telehealth service organized into eleven categories — weight loss, body composition, performance, recovery, skin and hair, hormonal balance, inflammation, immunity, sleep, cognitive health and labs — each naming its molecules. Clinical infrastructure is supplied by Altro Health, compounding is restricted to licensed 503A and 503B pharmacies, and lab panels run through Quest Diagnostics. It states availability in 50 states.

How it works

Quiz-led, described as roughly two minutes and nine questions, after which a clinician prescribes an individualized protocol. Every route through the site ends at that quiz or at a "create an account to learn more" wall, so nothing beyond the molecule names and the sourcing claims is available before you register. The pharmacy is not named individually, but the 503A/503B restriction is stated repeatedly (thirteen and eleven mentions respectively) rather than left as a single marketing line, and the site is unusually explicit about what it will not do: "NO GRAY MARKET. NO RUO."

Pricing transparency

There is none published. We crawled eighteen pages — the homepage, all eleven category pages, about, how-it-works, the quiz, and three legal pages — and found no dollar figure anywhere, for any product, including the lab panels. That is unusual even among the price-gated services on this board: Solaya MD is the only other provider in this batch with no price on any public page. It means Goldspan cannot be compared against anything here on cost without completing an intake, and readers who are shopping should treat it as an unknown rather than assuming it sits at any particular point in the range.

Branded vs compounded

Weight loss is tirzepatide and semaglutide, each offered as an injection with B12 for energy or glycine for muscle maintenance — a more considered pairing than most sites offer, since the choice is presented as a clinical one rather than an upsell. Elsewhere: sermorelin, tesamorelin, MOTS-C and Lipo-Mino for body composition; BPC-157 and a "Wolverine" blend for recovery; epithalon and selank/semax for cognition; glutathione and thymosin alpha-1 for immunity; DSIP for sleep; GHK-Cu topical and a "Glow" blend for skin; NAD+ for performance; and estradiol, vaginal estradiol, progesterone, enclomiphene and anastrozole under hormonal balance. ⚠ The site labels all of these "AVAILABLE PEPTIDES" and puts a "SELECT THIS PEPTIDE" control beneath each — including estradiol and progesterone, which are steroid hormones, anastrozole, a non-steroidal aromatase inhibitor, enclomiphene, a SERM, and NAD+, a coenzyme. None of those is a peptide. On the evidence: GLP-1 outcome data belongs to the branded products; sermorelin and tesamorelin act on the growth-hormone axis with thin long-term outcome data; BPC-157, epithalon, MOTS-C, DSIP and the nootropics have little to no controlled human outcome evidence; injected NAD+ has none.

Pros and watch-outs

What we like

Compounding restricted to licensed 503A and 503B pharmacies, stated repeatedly rather than once
Clinical partner named (Altro Health) and lab work run through Quest Diagnostics
Explicitly rejects gray-market and research-use-only product on its own homepage
Weight-loss line offers a B12-or-glycine choice framed as a clinical decision
Eleven categories with the molecules named, so you know what is on the menu before registering

Watch-outs

No price published anywhere — eighteen pages, not one figure, including for lab panels
Calls estradiol, progesterone, anastrozole, enclomiphene and NAD+ "peptides", which none of them is
Every route ends at a quiz or an account wall
No individual pharmacy named, only the 503A/503B category
A website-builder badge is still live in the production footer

Best for

Readers who rank sourcing discipline and a named clinical partner above seeing a price, and who are willing to register to find out what it costs.

Who should look elsewhere

Anyone comparing on price, and anyone who would be put off by a peptide-first service that misclassifies steroid hormones as peptides.

The evidence behind what Goldspan Health prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

Sermorelin: a real GHRH drug, read against the anti-aging pitch
An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.
BPC 157: what the evidence actually shows (and what it doesn't)
The 'healing peptide' has a deep rodent literature and almost no human data. A straight read of where the science stands.
NAD injections: how to get them near you or online, and what the evidence really says
Subcutaneous NAD+ injections are sold as a cheaper, at-home alternative to the IV drip — via “near me” clinics or telehealth shipped to your door. They’re compounded, not FDA-approved, and have no outcome trials; oral NR/NMN precursors are the route with the human data.
MOTS-c: real mitochondrial biology, absent human evidence
A genuine mitochondrial-derived peptide with interesting rodent data on metabolism and exercise — but no human outcome trials. Promising biology, not a proven therapeutic.
What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

How Goldspan Health compares

A few alternatives worth a look, depending on what you’re optimizing for.

NEUVÉ Health
Readers comparing injection against sublingual, and microdose against standard, on price
See NEUVÉ Health →
Solaya MD
Readers who want the medical group named and are willing to start an assessment to see a price
See Solaya MD →
Bayan Health
Readers who want a microdose entry point and their lab work priced in the same catalog
See Bayan Health →

Compare all providers side by side →

More GLP-1 telehealth reviews: Lighter YouAHBARxAlinwellAndrew MedsBelieve HealthClume Health

Julian Roth

Research & data · Reviewed and last verified September 2026

How we assessed this. This review reflects Aminoscope’s own read of Goldspan Health’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.

Frequently asked

What does Goldspan Health cost?: We cannot tell you, and neither can its website. We crawled eighteen pages — homepage, all eleven category pages, about, how it works, the quiz and three legal pages — and found no price for any product or lab panel. Every path ends at a two-minute quiz or a "create an account to learn more" wall. Only one other provider in this batch, Solaya MD, publishes as little. If price comparison is part of your decision, you will have to register to participate in it.
Is estradiol really a peptide?: No, and that is the error. Goldspan's Hormonal Balance category is headed "AVAILABLE PEPTIDES" and puts a "SELECT THIS PEPTIDE" control beneath estradiol, vaginal estradiol, progesterone, enclomiphene and anastrozole. Estradiol and progesterone are steroid hormones; anastrozole is a non-steroidal aromatase inhibitor; enclomiphene is a selective estrogen receptor modulator. The same labeling puts NAD+, a coenzyme, and low-dose naltrexone, an opioid antagonist, under the peptide heading too. It does not make the products unsafe, but on a service whose entire positioning is peptide expertise it is a careless signal.
What does "NO GRAY MARKET. NO RUO." actually mean?: RUO stands for research use only — vials sold as laboratory material, labeled not for human use, which a large gray market supplies to consumers who inject them anyway. By putting that line on its homepage, Goldspan is drawing a distinction between itself and that trade: it is saying everything it dispenses is a prescription compounded by a licensed 503A or 503B pharmacy. We think the distinction is the right one, and it is worth knowing that it exists — we refused a company from this same list, OzielRx, precisely because it sells research-use-only vials rather than prescriptions.
Who actually prescribes and compounds?: Prescribing is done by clinicians from Altro Health, which Goldspan names as its clinical infrastructure partner across the category pages and in its footer. Compounding is restricted to licensed 503A and 503B pharmacies — stated many times — but no individual pharmacy is named. Naming the clinical partner is more than most of this batch does; naming the specific pharmacy, as Clume Health and Nex Gen Health Rx do, would be more.
What is the difference between the B12 and glycine versions?: Goldspan offers both semaglutide and tirzepatide as an injection compounded either with B12 "for energy" or with glycine "for muscle maintenance". That framing is more considered than the usual B12 default, but treat the claimed benefits carefully: B12 is added routinely across this industry and its energy benefit in people who are not deficient is not established, and glycine as a compounding base is not the same as a studied intervention for preserving lean mass during GLP-1 treatment. Resistance training and adequate protein are the interventions with actual evidence behind them.
Is Goldspan Health legit?: Goldspan Health is a GLP-1 telehealth service you reach through an online questionnaire. The medications it names are Compounded semaglutide and Compounded tirzepatide. What it publishes up front: No price published anywhere on the public site; quiz-gated. 503A/503B only, Quest labs, 50 states. What our record does not establish: a single monthly price you can check before an intake and whether it bills insurance. Ask for those in writing before you pay.

Check availability →

Or compare every GLP-1 provider.